Ajanta Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	54,529	46,481	42,087	37,426	33,410
Other Revenue	1,721	-	-	-	-
Revenue	56,249	46,481	42,087	37,426	33,410
Revenue Growth (YoY)	21.02%	10.44%	12.45%	12.02%	15.62%
Cost of Revenue	11,838	11,429	11,210	11,102	8,840
Gross Profit	44,412	35,052	30,877	26,324	24,570
Selling, General & Admin	12,912	11,048	9,122	7,978	6,571
Other Operating Expenses	15,831	11,279	9,944	10,241	8,667
Operating Expenses	30,474	23,768	20,420	19,527	16,491
Operating Income	13,938	11,285	10,457	6,798	8,079
Interest Expense	-161.1	-207.3	-72.1	-58.4	-102
Interest & Investment Income	-	471.6	277.1	84.6	146.5
Currency Exchange Gain (Loss)	-	282.1	158.7	660.7	563.7
Other Non Operating Income (Expenses)	-	41.4	264.1	61.5	323.8
EBT Excluding Unusual Items	13,777	11,872	11,084	7,546	9,011
Gain (Loss) on Sale of Investments	-	25.2	20.1	-40	122.8
Gain (Loss) on Sale of Assets	-	-6	34.9	-53.5	-38.7
Pretax Income	13,777	11,892	11,139	7,453	9,095
Income Tax Expense	3,217	2,688	2,978	1,573	1,968
Net Income	10,560	9,204	8,162	5,880	7,127
Net Income to Common	10,560	9,204	8,162	5,880	7,127
Net Income Growth	14.73%	12.77%	38.81%	-17.50%	8.99%
Shares Outstanding (Basic)	125	125	126	128	130
Shares Outstanding (Diluted)	125	125	126	128	130
Shares Change (YoY)	-0.18%	-0.66%	-1.65%	-1.19%	-0.74%
EPS (Basic)	84.53	73.56	64.82	45.89	54.97
EPS (Diluted)	84.51	73.53	64.77	45.89	54.96
EPS Growth	14.93%	13.53%	41.14%	-16.50%	9.79%
Free Cash Flow	1,640	8,393	6,327	6,176	4,129
Free Cash Flow Per Share	13.13	67.05	50.21	48.20	31.84
Dividend Per Share	-	28.000	36.000	7.000	6.333
Dividend Growth	-	-22.22%	414.29%	10.53%	-
Gross Margin	78.95%	75.41%	73.36%	70.34%	73.54%
Operating Margin	24.78%	24.28%	24.84%	18.16%	24.18%
Profit Margin	18.77%	19.80%	19.39%	15.71%	21.33%
Free Cash Flow Margin	2.92%	18.06%	15.03%	16.50%	12.36%
EBITDA	15,669	12,522	11,638	7,952	9,173
EBITDA Margin	27.86%	26.94%	27.65%	21.25%	27.46%
D&A For EBITDA	1,731	1,238	1,181	1,154	1,094
EBIT	13,938	11,285	10,457	6,798	8,079
EBIT Margin	24.78%	24.28%	24.84%	18.16%	24.18%
Effective Tax Rate	23.35%	22.60%	26.73%	21.10%	21.64%
Revenue as Reported	56,249	47,426	42,933	38,413	34,567
Advertising Expenses	-	57.6	44.9	50.2	47.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.